Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2007
11/08/2007WO2007124668A1 Pharmaceutical composition comprising high concentrate of polydatin
11/08/2007WO2007124617A1 Coumarin derivatives, their preparation methods and their pharmaceutic compositions and uses
11/08/2007WO2007099348A3 Cathepsin propeptide and uses thereof
11/08/2007WO2007088099A3 Compounds for the treatment of ischemia and neurodegeneration
11/08/2007WO2007084868A3 Treatment of disorders by activation of the unfolded protein response
11/08/2007WO2007071357A3 Pharmaceutical composition comprising (e) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5 -yl- (3r, 5s) -3, 5-dihydr0xyhept-6-en0ic acid
11/08/2007WO2002046458A9 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
11/08/2007WO2002046220A9 Sequences upstream of the carp gene, vectors containing them and uses thereof
11/08/2007US20070259963 N-[5-methanesulfonyl-4-(4-methanesulfonyl-3-pentafluorosulfanylphenoxy)-2-methyl-benzoyl]guanidine; diagnostic agents for hypertension, diabetes, proliferative disorders; inhibitors of the cellular sodium-proton antiporter (Na/H exchanger); good absorption, bioavailability; angina pectoris, infarction
11/08/2007US20070259960 Compounds and methods for treatment of stroke
11/08/2007US20070259958 Prevention of Neutrophil Recruitment
11/08/2007US20070259941 Ramipril formulation
11/08/2007US20070259940 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
11/08/2007US20070259932 Benzimidazole derivatives, their production and use
11/08/2007US20070259922 Aryl, aryloxy, alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/08/2007US20070259918 2-Hydroxymethyl-3,4,5-Trihydroxy-1-(4-Pentyloxybenzyl) Piperidine as Glucosylceramide Synthase (Gcs) Inhibitor
11/08/2007US20070259914 Novel Piperidine Derivates as Modulators of Chemokine Receptor Ccr5.
11/08/2007US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases
11/08/2007US20070259892 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
11/08/2007US20070259891 Heterocycle-Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors
11/08/2007US20070259890 Compounds and Compositions as Ppar Modulators
11/08/2007US20070259887 Inhibitors of polyq-aggregation
11/08/2007US20070259884 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259878 High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
11/08/2007US20070259874 Phosphodiesterase Inhibitors
11/08/2007US20070259864 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction
11/08/2007US20070259845 Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe
11/08/2007US20070259833 accelerating vascular endothelial repair with a low haemorrhage risk in the event of thrombotic injuries; promoting revascularization in ischemic tissues and vascular modelling in thrombotic injuries; produced by the marine bacterium Alteromonas
11/08/2007US20070259829 Tolfenamic acid, diclofenac sodium, and diflunisal; non-steroidal anti-inflammatory drugs inhibited cancer cell growth, angiogenesis, metastasis of cancer cells by inducing degradation of Sp transcription factors; decreases expression of vascular endothelial growth factor; reducing toxicity of therapy
11/08/2007US20070259826 Chimeric (Double) Decoy
11/08/2007US20070259816 Expression vector comprising nucleotide sequences coding homeobox gene for use in identifying modulators for treatment and prevention of nervous system and seizure disorders
11/08/2007US20070259378 For drug screening; competitive binding; measuring activation by measuring [Ca2+] in the mixture
11/08/2007US20070259050 Combined Cosmetic or Therapeutic Preparation
11/08/2007US20070259022 Composition Comprising Statin
11/08/2007US20070259002 Botulinum Toxin Therapy of Heart Rhythm Disorders
11/08/2007US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007US20070258974 Diagnostics and Therapeutics for Diseases Associated with Puromycin Sensitive Aminopeptidase Npepps (Npepps)
11/08/2007US20070258948 Tissue Modeling in Embryonic Stem (Es) Cell System
11/08/2007US20070258945 G-GSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
11/08/2007US20070258920 Process for obtaining polyphenol extracts from cocoa beans, the resulting extracts and uses thereof
11/08/2007US20070258906 Methods and devices for detection and therapy of atheromatous plaque
11/08/2007US20070258902 Method for Assessing Atherosclerosis
11/08/2007DE102006020604A1 Flüssige Arzneimittelformulierung Liquid pharmaceutical formulation
11/08/2007DE102005060880A9 Spezialextrakt zur Verwendung als Antiarrhytmikum bei Herzrhythmusstörungen und zur Verbesserung der Koronarperfusion sowie dessen Herstellung Special extract for use as anti-arrhythmic agent for cardiac arrhythmias and improves coronary and its production
11/08/2007CA2823767A1 Abnormal cannabidiols as agents for lowering intraocular pressure
11/08/2007CA2823724A1 Abnormal cannabidiols as agents for lowering intraocular pressure
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007CA2650607A1 Compositions and methods for the treatment of cardiovascular disease
11/08/2007CA2650567A1 Use of cbx cannabinoid receptor modulators as potassium channel modulators
11/08/2007CA2650566A1 Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators
11/08/2007CA2650403A1 Compositions comprising theaflavins and gallates thereof useful as fat absorption inhibitors
11/08/2007CA2650393A1 Heterocyclyl-substituted fused pyrazole derivatives and their use
11/08/2007CA2650132A1 Further medical uses of antisecretory protein
11/08/2007CA2649373A1 Compositions for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders
11/08/2007CA2649363A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitor activity
11/08/2007CA2647933A1 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
11/08/2007CA2647815A1 Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia
11/08/2007CA2634871A1 Treatment of renal disorders, diabetic nephopathy and dyslipidemias
11/07/2007EP1852505A1 Mutations in ion channels
11/07/2007EP1852503A1 Il-13 production inhibitor
11/07/2007EP1852433A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
11/07/2007EP1852431A1 Optically active tetrahydronaphthalene derivative
11/07/2007EP1852426A1 Process for production of optically active ppar-activating compound and intermediate of the same
11/07/2007EP1852423A1 Crystal of 4(3h)-quinazolinone derivative
11/07/2007EP1852420A1 Indole compound and use thereof
11/07/2007EP1852124A1 Fibrosis inhibitor for implanted organ
11/07/2007EP1852118A1 Method for producing adsorptive porous body
11/07/2007EP1852116A1 Pharmaceutical compositions of amlodipine and atorvastatin
11/07/2007EP1851739A2 Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto
11/07/2007EP1851197A2 Phenylazetidinone derivatives
11/07/2007EP1850848A1 Tetracyclic sulfonamide compounds and methods of use thereof
11/07/2007EP1850841A1 Methods for qt interval control
11/07/2007EP1804795A4 Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
11/07/2007EP1513526B1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
11/07/2007EP1423707B1 Methods of screening molecules that are used to prevent cardiovascular diseases
11/07/2007EP1401408A4 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/07/2007EP1400521B1 Piperazine compounds
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007EP1317276B1 Therapeutic use of a recombinant erythropoietin omega having high activity and reduced side effects
11/07/2007EP1017713B1 CYCLIC ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
11/07/2007EP0833624B1 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
11/07/2007CN101068806A (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate
11/07/2007CN101068792A Amorphous and polymorphic forms of telmisartan sodium
11/07/2007CN101068571A Method of enhancing absorptions of transmucosal administration formulations
11/07/2007CN101068560A Method of screening toxin-neutralizing peptide, STX2 inhibitory peptide and Vero toxin-neutralizing agent
11/07/2007CN101068548A Method for reduction, stabilization and/or prevention of rupture of lipid rich plaque
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066439A Wind dispelling and obstruction eliminating capsule and its prepn
11/07/2007CN101066411A Prepn of medicine composition of docombent corydalis rhizome
11/07/2007CN101066391A Medicine composition for treating hypertension
11/07/2007CN101066358A Sanitary health Chinese medicine cushion
11/07/2007CN101066335A Chinese medicine for treating thromboangiitis obliterans and phlebitis and its prepn
11/07/2007CN101066325A Chinese herbal medicine liniment for treating paralysis
11/07/2007CN101066323A Sanhuang heat clearing away cold decoction
11/07/2007CN101066311A Total jasminoidin extract and its prepn process
11/07/2007CN101066303A Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its prepn
11/07/2007CN101066291A Chinese medicine composition for transquilizing, warming Yang, benefiting Qi and nourishing heart and its prepn
11/07/2007CN101066272A Application of compound 6-furfuryl amino purine in preparing medicine for treating myocardial tissue oxidizing damage
11/07/2007CN101066270A Application of compound 6-furfuryl amino purine in preparing medicine for treating myocardial ischemia damage
1 ... 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 ... 1595